ifenprodil has been researched along with Pulmonary Disease, Chronic Obstructive in 1 studies
ifenprodil: NMDA receptor antagonist
Pulmonary Disease, Chronic Obstructive: A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huo, XL | 1 |
| Min, JJ | 1 |
| Pan, CY | 1 |
| Zhao, CC | 1 |
| Pan, LL | 1 |
| Gui, FF | 1 |
| Jin, L | 1 |
| Wang, XT | 1 |
1 other study available for ifenprodil and Pulmonary Disease, Chronic Obstructive
| Article | Year |
|---|---|
Efficacy of lovastatin on learning and memory deficits caused by chronic intermittent hypoxia-hypercapnia: through regulation of NR2B-containing NMDA receptor-ERK pathway.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Chronic Disease; Disease Models, Animal | 2014 |